Cargando…
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
The rho-associated coiled-coil–containing protein kinase-2 (ROCK2) signaling pathway regulates the Th17/regulatory T cells balance and controls profibrotic pathways. Selective ROCK2 inhibition with belumosudil (KD025) may offer a novel approach to the management of chronic graft-versus-host disease...
Autores principales: | Jagasia, Madan, Lazaryan, Aleksandr, Bachier, Carlos R., Salhotra, Amandeep, Weisdorf, Daniel J., Zoghi, Behyar, Essell, James, Green, Laurie, Schueller, Olivier, Patel, Jeegar, Zanin-Zhorov, Alexandra, Weiss, Jonathan M., Yang, Zhongming, Eiznhamer, David, Aggarwal, Sanjay K., Blazar, Bruce R., Lee, Stephanie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189612/ https://www.ncbi.nlm.nih.gov/pubmed/33877856 http://dx.doi.org/10.1200/JCO.20.02754 |
Ejemplares similares
-
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
por: Cutler, Corey, et al.
Publicado: (2021) -
Belumosudil: First Approval
por: Blair, Hannah A.
Publicado: (2021) -
Isoform-specific targeting of ROCK proteins in immune cells
por: Zanin-Zhorov, Alexandra, et al.
Publicado: (2016) -
Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials
por: DeFilipp, Zachariah, et al.
Publicado: (2022) -
Correction to: Belumosudil: First Approval
por: Blair, Hannah A.
Publicado: (2021)